4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Arecor Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Arecor Limited | 41 | 2023-02-27 | 2024-02-16 |
| AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study AT247, NovoLog, Fiasp - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Arecor Limited | 24 | 2022-01-03 | 2022-09-13 |
| AT278 and NovoRapid® in Glucose Clamp Study AT278, NovoRapid - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Arecor Limited | 38 | 2020-12-02 | 2021-07-21 |
| AT247, NovoRapid® and Fiasp® in Glucose Clamp Study NovoRapid, Fiasp, AT247 - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Arecor Limited | 18 | 2019-04-12 | 2019-09-30 |
Diabetes Mellitus, Type 1 (3) · Diabetes Mellitus, Type 2 (1)
Insulin Aspart (4)
Austria (3) · United States (1)